Jack

Trade your trade📈

Take profits 🤑

Move on to the next trade 👍🏽

Rinse and Repeat

[Jack @limitlessgains]

@TheRoaringKitty $GME $AMC

[Marshall Green @MarshallGreen_]

Feels good to wake up a champ

[Jack @limitlessgains]

@shwinnypooh It'll come out in the Knicks documentary/docuseries

[Jack @limitlessgains]

@moonmarket @TT_stocks_ @PeterCarli28957 @greatstockpicks @HunterAllen4

[Jack @limitlessgains]

Could $RGNT pull a $WOK , $SMX or $HKD ?

[NBA @NBA]

FOR THE FIRST TIME IN 53 YEARS, THE KNICKS ARE NBA CHAMPIONS 🏆

New York defeats San Antonio 4-1 in the NBA Finals, capturing their third championship in franchise history!

[Jack @limitlessgains]

@stockplaymaker1 👍

[NarutOTC @NarutOTC_]

$FITY Looks like we’re ready for the next leg, Keep eye 👀

[trading fool @tradingfool42]

$FITY i wonder why this didn't get more attention last week. what am i missing? i'm not in this one but it is interesting to watch and keep in mind. we will see

[NarutOTC @NarutOTC_]

$FITY They found it? 7’s up and thin 👀

[Terry @TerryChenOK]

$FITY .0007 👀

[Fifty 1 Labs $FITY @Fifty1Labs]

$FITY ACCELERATES AI-POWERED PEPTIDE BIOTECH PUSH INTO MUSCULOSKELETAL HEALTH! 🧬💪
AI-enabled discovery + clinical-stage development targeting injury recovery, sports performance & tissue healing for muscle, tendon, ligament & bone conditions.
“Bringing scientific rigor, innovation & legitimacy to the peptide sector” — CEO Joel Gagnier
Full release: https://t.co/Rwa4zSUYrQ
#FITY #PeptideBiotech #MSKHealth #AI

[ACCESS Newswire @AccesswireNews]

$FITY Fifty 1 Labs, Inc. Accelerates Peptide Biotechnology Push into Musculoskeletal Health https://t.co/lcfzVxRnYm

[NarutOTC @NarutOTC_]

$FITY Leaving trips soon? 👀
sleeper waking up 🔥
AI + peptide biotech play targeting massive MSK market

Catalysts loading:
-First-in-human trials
-Strategic partnerships
-AI discovery engine scaling
-600M+ shares dilution CUT 💣

Low float + hot sector = explosive potential 🚀

[ORCA @PennyOrca]

$FITY

[OFF THE CHART TRADING @Bossboater1]

$FITY Lets see 002s

[HumanityFirst @speechwave]

$FITY 🔥🔥🚀🚀

[NarutOTC @NarutOTC_]

$FITY

[Johnze @Eli12342827]

$FITY

Next one out of trips. Company paying with own funds to retire shares

[Freeway @Spes_plena]

$FITY As of April 14, 2026, Fifty 1 Labs, Inc. (FITY) has moved to significantly tighten its capital structure.

While the exact "free float" (shares currently available for public trading) isn't explicitly listed as a single figure in real-time, the company just completed a major move to prevent its expansion:

Recent Structural Changes
Shares Removed from Potential Float: The company retired 1,748,933 shares of Series B Preferred Stock.

Dilution Prevention: This action permanently blocked those preferred shares from converting into approximately 612,126,550 common shares.

Impact: This move was specifically designed to eliminate share overhang and "clean up" the public vehicle, making the existing float less susceptible to massive dilution.

Current Share Data
Shares Outstanding: Approximately 976.86 million shares (as of mid-2026 reporting).

Previous Reporting: For context, the company reported 657,068,600 common shares outstanding as of September 30, 2025.

Market Status: The stock currently trades on the OTCMKTS with a market cap of roughly $400,000 to $900,000 depending on the day's volatility.

Summary: The "float" is currently being aggressively managed by management to reduce supply. By using internal funds to buy back and retire convertible preferred shares, they have effectively deleted over 612 million potential new shares that would have otherwise entered the public market.